Harbor Healthcare Advises La Vita Compounding On Its Sale & Strategic Partnership
San Diego, November 2023 - La Vita Compounding Pharmacy, a trusted 503A compounding pharmacy, is proud to announce its acquisition[...]
MoreSan Diego, November 2023 - La Vita Compounding Pharmacy, a trusted 503A compounding pharmacy, is proud to announce its acquisition[...]
MoreHarbor Healthcare is pleased to announce the successful sale of a Southern California based long-term care pharmacy, servicing over 5,100[...]
MoreHarbor Healthcare Consultants is pleased to announce the successful sale of Hopkinton Drug Compounding Pharmacy, a Massachusetts-based 503A compounding pharmacy[...]
MoreCalifornia, October 2022 - Harbor Healthcare is pleased to announce the successful sale of a multi-location long-term care (LTC) pharmacy,[...]
MoreMidwest, September 2022 - Harbor Healthcare Consultants is pleased to announce the successful sale of Custom Rx 503A compounding pharmacy[...]
MoreMichigan, March 2022 - Harbor Healthcare Consultants is pleased to announce the successful sale of Pharmacy Solutions, a Michigan-based 503A[...]
MoreCalifornia, January 2022 - Harbor Healthcare is pleased to announce the successful sale of a California based home infusion pharmacy,[...]
MoreMassachusetts, January 2022 - Harbor Healthcare is pleased to announce the successful sale of a Massachusetts based long-term care (LTC)[...]
MoreNortheastern United States, November 2021 - Harbor Healthcare is pleased to announce the successful sale of a Northeastern based long-term[...]
MorePennsylvania, May 2021 - Harbor Healthcare is pleased to announce the successful sale of a Pennsylvania based long-term care (LTC)[...]
More